EMA Withdrawn: Fortovase (saquinavir) — Roche Registration Ltd.

View source ↗

Summary

Fortovase (saquinavir) has been withdrawn from the European market by Roche Registration Ltd., with the decision dating 20 August 1998.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Fortovase (saquinavir)

Snippet

Status: Withdrawn. Therapeutic area: HIV Infections. MAH: Roche Registration Ltd.. Decision date: 20/08/1998